Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Change in Accured Expenses (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Change in Accured Expenses for 6 consecutive years, with -$5.6 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 161.89% to -$5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$30.2 million through Dec 2025, down 304.19% year-over-year, with the annual reading at -$30.2 million for FY2025, 304.19% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$5.6 million at Lexicon Pharmaceuticals, up from -$14.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $11.1 million in Q2 2025, with the low at -$21.7 million in Q1 2025.
  • Average Change in Accured Expenses over 3 years is -$747250.0, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Change in Accured Expenses surged 443.93% in 2024, then tumbled 257.86% in 2025.
  • Over 3 years, Change in Accured Expenses stood at -$2.7 million in 2023, then soared by 443.93% to $9.1 million in 2024, then plummeted by 161.89% to -$5.6 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$5.6 million, -$14.0 million, and $11.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.